The original description of cerebral palsy (CP) contained case histories suggesting that
perinatal environmental stressors resulted in brain injury and neurodevelopmental disability …

Cerebral palsy (CP) is a clinical term used to describe a spectrum of movement and posture
disorders resulting from non-progressive disturbances in the develo** fetal brain. The …

Cerebral palsy (CP) has historically been attributed to acquired insults, but emerging
research suggests that genetic variations are also important causes of CP. While microarray …

Aim To compare, in term‐born children with cerebral palsy (CP), the characteristics of those
who exhibit detectable risk factors for CP at birth with those who do not. Method This was a …

Group B Streptococcus (GBS) is one of the most common bacteria responsible for placental
and neonatal infection and inflammation resulting in lifelong neurobehavioral impairments …

A growing number of genes have been identified in individuals with cerebral palsy (CP);
however, many of these studies have poor compliance with the cerebral palsy clinical …

The Zika virus (ZIKV) epidemic in the Americas has highlighted the significant impact of
virally induced prenatal brain injury on child neurodevelopment. Eight years after the ZIKV …

The current era of high-throughput analysis-driven research offers invaluable insights into
disease etiologies, accurate diagnostics, pathogenesis, and personalized therapy. In the …

Cerebral palsy (CP) is the most common motor disability in children, characterized by
diverse clinical manifestations and often uncertain etiology, which has spurred increasing …

Targeted gene therapy may revolutionize disease treatment by precisely treating genetic
defects. This method targets particular cells or tissues with therapeutic genes to treat a …